Skip to content

The Effect of Tympanostomy Tube Insertion on Sleep in Children With Chronic Otitis Media With Effusion

The Effect of Tympanostomy Tube Insertion on Sleep in Children With Chronic Otitis Media With Effusion

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02477735
Enrollment
30
Registered
2015-06-23
Start date
2015-06-30
Completion date
2017-12-31
Last updated
2015-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Otitis Media With Effusion, Sleep Disturbances

Brief summary

The purpose of this study is to investigate the prevalence of sleep disturbances in children with Chronic Otitis Media with Effusion (COME) and the effect of tympanostomy tube insertion (TTI) on sleep disturbances.

Detailed description

Comparison of sleep disturbances will be between infants with Chronic Otitis Media with Effusion (COME) who will be referred for tympanostomy tube insertion (TTI) (study group) and healthy infants that were recruited from the community well-baby clinics (control group). To evaluate sleep patterns, parents of the study group will complete two validated sleep questionnaires assessing the infant's typical sleep patterns based on parental reports. A week before TTI and 1 week to 1 month after the surgery, sleep will be evaluate by actigraph for a week long.

Interventions

DEVICEActigraphy

Actigraphy will be conducted for each participant for 7 consecutive nights prior to TTI and for 7 consecutive nights 4-6 weeks following TTI.

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 36 Months
Healthy volunteers
No

Inclusion criteria

* Age: 6-36 months * Referred for tympanostomy tube insertion as a treatment for COME.

Exclusion criteria

* Snoring and sleep disordered breathing (SDB) * Chronic medical condition * referred for TTI and adenoidectomy/tonsillectomy

Design outcomes

Primary

MeasureTime frame
Actigraphy measurementsUp to two years

Secondary

MeasureTime frame
OSA-18 questionnaire scoreUp to two years
Brief Infant Sleep Questionnaire (BISQ) scoreUp to two years

Countries

Israel

Contacts

Primary ContactGad Fishman, Doctor
gadf@tlvmc.gov.il+972-2-4266362

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026